Media

Media

filter by theme
WOMEN's HEALTH
ENDOCRINOLOGY
Cell therapy
CORPORATE
REGULATORY

Février 2009

17

HRA Pharma and Gedeon Richter Enter into Marketing and Distribution Agreement

December 2008

02

HRA Pharma Strengthens European Operations with German Affiliate.

December 2007

04

HRA Pharma enters licensing agreement with PregLem to develop and commercialise ulipristal for gynecological disorders.

November 2007

27

HRA Pharma is sponsoring the « Afrique en créations » prize aimed to reward the work of a young, talented African photographer.

March 2007

26

HRA Pharma commences UK-based Phase III trial of Ella®, a second-generation emergency contraceptive

Février 2007

28

HRA Pharma invest an additional € 2.5 M in cell therapy through its subsidiary Celogos

Février 2007

15

Stem Cell Sciences and Celogos sign a licensing deal on autogenous myoblast transplantation

December 2006

07

HRA Pharma commences US Phase III trial of new emergency contraceptive

filter by theme
WOMEN's HEALTH
ENDOCRINOLOGY
Cell therapy
CORPORATE
REGULATORY
closeyou are leaving hra pharma
You are now leaving www.hra-pharma.com and being redirected to an external website which might not be under control of HRA Pharma.
do you want to proceed ?